Copy and Edit

A N T I C O A G U L A N T S

Description

pharmacy Cardio Mind Map on A N T I C O A G U L A N T S, created by Kaytlynn Fisher on 03/04/2019.
Kaytlynn Fisher
Mind Map by Kaytlynn Fisher, updated more than 1 year ago
Kaytlynn Fisher
Created by Kaytlynn Fisher over 5 years ago
239
0
0

Resource summary

A N T I C O A G U L A N T S
  1. MOA
    1. HIGH MOLECULAR WEIGHT HEPARINS
      1. SIGNIFICANT inhibition of Xa & IIa • • • MINOR inhibition of VIIa, IXa, & XIIa • • • Active clotting factors INACTIVATED • • • INDIRECT thrombin inhibitor • • • enhances effects of antithrombin III
        1. HEPARIN
        2. LOW MOLECULAR WEIGHT HEPARINS
          1. ENHANCES the effects of antithrombin III • • • SIGNIFICANT inhibition of Xa • • • Some inhibition of IIa • • • Active clotting factors INACTIVATED
            1. ENOXAPARIN • • Lovenox
              1. DALTEPARIN • • Fragmin
              2. VITAMIN K ANTAGONIST
                1. Interacts with Vit K cycle • • • Factor II, VII, IX, & X • • • INHIBITS Vit K epoxide reductase ( VKORC1 ) which converts Vit K to its activa form ( KH2 ) → → No longer a cofactor of carboxylase → → less K → Less K dependent clotting factors produced → ALSO inhibits protein C and S
                  1. WARFARIN • • Coumadin
                  2. FACTOR Xa INHIBITORS
                    1. ACUTE
                      1. FONDAPARINUX • • Atrixa
                        1. Augments function of ATII • • Significant inhibition of Xa only • • Active clotting factors inactivated (Only Xa)
                        2. CHRONIC
                          1. DOES NOT AFFECT ANTITHROMBIN • • • Directly inhibits Factor Xa by BLOCKING the active site
                            1. APIXABAN • Eliquis • • • • RIVAROXABAN • Xarelto • • • • EDOXABAN • Sayvasa • • • • BETRIXABAN • Bevyxxa
                          2. DIRECT THROMBIN INHIBITORS
                            1. DABIGATRAN • Pradaxa • • • • ARGATROBAN • • • • BIVALIRUDIN • Angiomax • • • • DESIRUDIN • Iprivask
                              1. DIRECTLY inhibits Factor IIa ( Thrombin ) by binding the active site
                              2. FIBRINOLYTICS
                                1. Breaks up clots by converting plasminogen to plasmin
                                  1. ALTEPASE • Activase / Cathflo
                                2. INDICATIONS
                                  1. MONITORING
                                    1. REQUIRED MONITORING
                                      1. HEPARIN
                                        1. APTT (ACTIVATED PARTIAL THROMBOPLASTIN TIME) • • • GOAL = 1.5 - 2.5 CONTROL RANGE
                                      2. NO REGULAR - REQUIRED MONITORING
                                      3. INTERACTIONS
                                        1. CONTRAINDICATIONS
                                          1. CONTRAINDICATED IN CRCL < 30 ML/MIN
                                            1. DABIGATRAN (- PRADAXA -)
                                              1. FONDAPARINUX (- ATRIXA -)
                                            2. AGENT - AGENT CONVERSION
                                              1. FORMULATIONS
                                                1. ORAL
                                                  1. WARFARIN
                                                    1. APIXABAN
                                                      1. RIVAROXABAN
                                                        1. EDOXABAN
                                                          1. BETRIXABAN
                                                            1. DABIGATRAN
                                                            2. S Q
                                                              1. ENOXAPARIN
                                                                1. DALTEPARIN
                                                                  1. HEPARIN - NOT COMMON
                                                                  2. IV
                                                                    1. HEPARIN
                                                                      1. FONDAPARINUX
                                                                        1. ARGATROBAN
                                                                          1. BIVALIRUDIN
                                                                            1. DESIRUDIN
                                                                              1. ATLEPASE
                                                                                1. RETEPLASE
                                                                                  1. TENECTEPLASE
                                                                                2. DRUG SPECIFIC POINTS
                                                                                  1. ADRs
                                                                                    1. COUNSELING
                                                                                      1. REVERSAL AGENTS
                                                                                        1. MEDICATION CLASS
                                                                                          1. HIGH MOLECULAR WEIGHT HEPARIN (HMWH)
                                                                                            1. UNFRACTIONATED HEPARIN (UFH)
                                                                                            2. LOW MOLECULAR WEIGHT HEPARINS
                                                                                              1. ENOXAPARIN - (LOVENOX)
                                                                                                1. DALTEPARIN - (FRAGMIN)
                                                                                                2. COURMARIN ( - VIT K - ) DERIVATIVE
                                                                                                  1. WARFARIN ( - COUMADIN - )
                                                                                                  2. FACTOR Xa INHIBITORS
                                                                                                    1. FONDAPARINUX ( - ARIXTRA - )
                                                                                                      1. APIXABAN ( - ELIQUIS - )
                                                                                                        1. RIVAROXABAN ( - XARELTO - )
                                                                                                          1. EDOXABAN ( - SAVAYSA - )
                                                                                                            1. BETRIXABAN ( - BEVYXXA - )
                                                                                                            2. DIRECT THROMBIN INHIBITORS
                                                                                                              1. DABIGATRAN ( - PRADAXA - )
                                                                                                                1. ARGATROBAN
                                                                                                                  1. BIVALIRUDIN (- ANGIOMAX -)
                                                                                                                    1. DESIRUDIN (- IPRIVASK -)
                                                                                                                    2. FIBRINOLYTICS
                                                                                                                      1. ATLEPASE (- ACTIVASE / CATHFLO -)
                                                                                                                        1. RETEPLASE (- RATEVASE -)
                                                                                                                          1. TENECTEPLASE (- TNKase -)

                                                                                                                        Media attachments

                                                                                                                        Show full summary Hide full summary

                                                                                                                        Want to create your own Mind Maps for free with GoConqr? Learn more.

                                                                                                                        Similar

                                                                                                                        Management of Anticoagulation
                                                                                                                        Kaytlynn Fisher
                                                                                                                        Chapter 11: Cardiorespiratory Training: Programming and Progressions
                                                                                                                        preethamroymoras
                                                                                                                        Histology of Heart and Blood Vessels
                                                                                                                        Hannah Tribe
                                                                                                                        infective endocarditis
                                                                                                                        v.djabatey
                                                                                                                        Stroke (Lectures I & II)
                                                                                                                        Matthew Coulson
                                                                                                                        psychotropics
                                                                                                                        vernerl01
                                                                                                                        Cardiac Pharmacology Part 2 - Nursing
                                                                                                                        Eiei Uyhp
                                                                                                                        Cardiorespiratory system
                                                                                                                        stackety
                                                                                                                        REVIEW FOR P.E. TEST
                                                                                                                        Amber Rose
                                                                                                                        GTN formulations
                                                                                                                        jenny schneider
                                                                                                                        PHSI3011 07-1 Cardiorespiratory adaptation to high altitude
                                                                                                                        Michael Jardine
                                                                                                                        Browse Library